Journal article
Maternal antibody parameters of cattle and calves receiving EG95 vaccine to protect against Echinococcus granulosus
DD Heath, C Robinson, MW Lightowlers
Vaccine | ELSEVIER SCI LTD | Published : 2012
Abstract
Cattle may act as hosts for the transmission of the cestode parasite Echinococcus granulosus and play a role in transmission of the parasite leading to human cystic echinococcosis (CE). The recombinant EG95 vaccine has been shown to be able to protect cattle and other intermediate host species against CE. Ideally the immunisation of bovines against E. granulosus, using EG95 vaccine, should occur early in life so as to provide maximum protection against the establishment of hydatid cysts. Maternally derived antibody from vaccinated cows may provide some protection for the neonate, but may also interfere with the active response to vaccination. Experiments were undertaken to determine the opti..
View full abstractRelated Projects (2)
Grants
Awarded by Foundation for Research, Science and Technology
Funding Acknowledgements
This work was supported by the New Zealand Foundation for Research, Science and Technology (FRST). Funding from the Australian National Health and Medical Research Council (grant numbers 350279, 628320, 100354) (ML) is acknowledged.